4.7 Article

Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Epigenetic plasticity of enhancers in cancer

Jie Yao et al.

TRANSCRIPTION-AUSTIN (2020)

Review Radiology, Nuclear Medicine & Medical Imaging

Imaging strategy in recurrent ovarian cancer: a practical review

Lucia Manganaro et al.

ABDOMINAL RADIOLOGY (2019)

Article Oncology

The hyper-activation of transcriptional enhancers in breast cancer

Qing-Lan Li et al.

CLINICAL EPIGENETICS (2019)

Article Chemistry, Multidisciplinary

Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer

Ling-jiao Zou et al.

ACTA PHARMACOLOGICA SINICA (2019)

Article Oncology

New strategies in ovarian cancer treatment

Jung-Min Lee et al.

CANCER (2019)

Review Oncology

The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications

Pingping Guo et al.

PATHOLOGY & ONCOLOGY RESEARCH (2018)

Article Chemistry, Medicinal

Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases

Michael R. Michaelides et al.

ACS MEDICINAL CHEMISTRY LETTERS (2018)

Article Biochemistry & Molecular Biology

Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors

Wenchao Lu et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2018)

Review Biochemistry & Molecular Biology

Epigenetics in ovarian cancer: premise, properties, and perspectives

Qilian Yang et al.

MOLECULAR CANCER (2018)

Article Medicine, Research & Experimental

Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer

Narsis Attar et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)

Article Multidisciplinary Sciences

YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer

Wenyi Mi et al.

NATURE COMMUNICATIONS (2017)

Review Oncology

Targeting Histone Acetylation Readers and Writers in Leukemia and Cancer

Christopher B. Benton et al.

CANCER JOURNAL (2017)

Review Cell Biology

The promise of epigenetic therapy: reprogramming the cancer epigenome

Andrew D. Kelly et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)

Article Biochemistry & Molecular Biology

Super-Enhancers in the Control of Cell Identity and Disease

Denes Hnisz et al.

Article Biochemistry & Molecular Biology

Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation

Manuela Delvecchio et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)

Review Biochemistry & Molecular Biology

Chemical Approaches To Understand the Language of Histone Modifications

Abhinav Dhall et al.

ACS CHEMICAL BIOLOGY (2011)

Review Cell Biology

Regulation of chromatin by histone modifications

Andrew J. Bannister et al.

CELL RESEARCH (2011)

Article Multidisciplinary Sciences

Adenovirus small e1a alters global patterns of histone modification

Gregory A. Horwitz et al.

SCIENCE (2008)

Review Biochemistry & Molecular Biology

Chromatin modifications and their function

Tony Kouzarides

Article Biochemistry & Molecular Biology

p300/CBP and cancer

NG Iyer et al.

ONCOGENE (2004)

Article Multidisciplinary Sciences

Histone sumoylation is associated with transcriptional repression

Y Shilo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Multidisciplinary Sciences

The language of covalent histone modifications

BD Strahl et al.

NATURE (2000)